Interface biologics has demonstrated commercialization success with its surface modification technology and is well positioned to drive further incremental value with its drug delivery technology.
IBI’s Epidel™ anti-infective oligomers/polymers allow for pharmaceuticals to be coated directly onto the medical device providing for long term anti-microbial effectiveness. The technology is flexible and can provide solutions for multiple medical devices with different surface morphology and characteristics (e.g. mesh, polymeric, metallic) and manufacturing processes (e.g. coating, extrusion, heat press) and a broad range of compatible drugs.
There are two active development projects using the Epidel technology:
1) an anti-microbial dental implant to address infection issues for both de novo implants as well as peri-implantitis (product extension opportunity: orthopedic fixation screws/plates)
2) a coated Dacron® cuff for peritoneal dialysis catheters, dialysis catheters and/or tunneled PICCs (product extension opportunity: hernia mesh)
Anti-microbial dental implants and orthopedic fixation devices
Coated percutaneous cuffs for dialysis catheters, tunneled PICCs and other applications